The new definition of metabolic dysfunction-associated steatotic liver disease: the role of ultrasound and elastography
Ultrasonography · 01.05.2025 · 44 (3) · 189-201
DOI: 10.14366/usg.24219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ultrasonography, erschienen am 01.05.2025. Verfasst von Xinrui Jin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Therapeutics, Medical Data Analytics Center, The Chinese University of Hong Kong, Hong Kong, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
In 2023, nonalcoholic fatty liver disease was renamed metabolic dysfunction-associated steatotic liver disease by the American and European liver associations. This new nomenclature recognizes metabolic dysfunction as the central driver of the disease, and the diagnostic criteria now require the presence of hepatic steatosis plus at least one of five cardiometabolic risk factors. B-mode ultrasonography remains the most common and practical method for detecting hepatic steatosis, although newer ultrasound techniques based on attenuation, backscatter, and speed of sound have gained traction as tools to diagnose and quantify hepatic steatosis. Additionally, ultrasound elastography is increasingly used in routine clinical practice to assess liver fibrosis, diagnose cirrhosis, and identify clinically significant portal hypertension.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine and Therapeutics, Medical Data Analytics Center, The Chinese University of Hong Kong, Hong Kong, China.
- State Key Laboratory of Digestive Disease, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Zitieren
APA
Jin, X., Yip, T. C., Wong, G. L., Wong, V. W., & Lai, J. C. (2025). The new definition of metabolic dysfunction-associated steatotic liver disease: the role of ultrasound and elastography. Ultrasonography, 44(3), 189-201. https://doi.org/10.14366/usg.24219
Vancouver
Jin X, Yip TC, Wong GL, Wong VW, Lai JC. The new definition of metabolic dysfunction-associated steatotic liver disease: the role of ultrasound and elastography. Ultrasonography. 2025;44(3):189-201. doi:10.14366/usg.24219
BibTeX
@article{Jin2025,
author = {Jin, Xinrui and Yip, Terry Cheuk-Fung and Wong, Grace Lai-Hung and Wong, Vincent Wai-Sun and Lai, Jimmy Che-To},
title = {The new definition of metabolic dysfunction-associated steatotic liver disease: the role of ultrasound and elastography},
journal = {Ultrasonography},
year = {2025},
volume = {44},
number = {3},
pages = {189--201},
doi = {10.14366/usg.24219}
}
EUVIMED